World Journal of Dentistry

Register      Login

VOLUME 6 , ISSUE 1 ( January-March, 2015 ) > List of Articles


An in vitro Evaluation of Antibacterial Activity of Curcumin against Aggregatibacter actinomycetemcomitans

Kishore Bhat, Abdulpur Mallikarjun Savita, Charu Dawra

Citation Information : Bhat K, Savita AM, Dawra C. An in vitro Evaluation of Antibacterial Activity of Curcumin against Aggregatibacter actinomycetemcomitans. World J Dent 2015; 6 (1):16-19.

DOI: 10.5005/jp-journals-10015-1306

Published Online: 01-03-2015

Copyright Statement:  Copyright © 2015; The Author(s).



Development of bacterial resistance to the available antibiotics and increasing popularity of traditional medicine has led researchers to investigate the antibacterial compounds in plants. In this context, curcumin has been shown to have a range of beneficial properties, like antimicrobial and anti-inflammatory properties, which might be favorable for the treatment of inflammatory diseases like periodontitis.

Aims and objectives

The primary objective of this study was to evaluate the antibacterial potential of curcumin against Aggregatibacter actinomycetemcomitans (ATCC 29523).

Materials and methods

The bacterial strains of A. actinomycetemcomitans from the stock were revived and transferred to sterile brain heart infusion (BHI) broth. Minimum inhibitory concentration (MIC) was determined by serial broth dilution of curcumin. The last tube with clear supernatant was considered to be without any growth and taken as MIC value.


The mean MIC value of curcumin against A. actinomycetemcomitans (ATCC 29523) was reported to be 0.2 μg/ml.


Thus, it can be concluded that the pleiotropic activities of curcumin derived from its complex chemistry and its ability to influence and control the multiple signaling pathways, makes it a suitable and safer option for the treatment of periodontal diseases.

How to cite this article

Savita AM, Dawra C, Bhat K. An in vitro Evaluation of Antibacterial Activity of Curcumin against Aggregatibacter actinomycetemcomitans. World J Dent 2015;6(1):16-19.

PDF Share
  1. Interspecies interactions within oral mircobial communities. Microbiol Mol Biol Rev 2007;71(4):653-670.
  2. J Clin Periodontol 2002;29(11):1023-1028.
  3. Microbial etiology of periodontal disease—Mini Review. Facta Universitatis 2008;15(1):1-6.
  4. Nonsurgical Approaches for the treatment of periodontal diseases. Dent Clin N Am 2005;49(3):611-636.
  5. Comparative evaluation of 1% curcumin solution and 0.2% chlorhexidine irrigation as an adjunct to scaling and root planing in management of chronic periodontitis: A clinico-microbiological study. JPBMS 2012;14:1-6.
  6. Effect of controlled-release PeriochipTM on clinical and microbiological parameters in patients of chronic periodontitis. J Indian Soc Periodontol 2013;17(5):605-611.
  7. Difference of curcumin content in Curcuma longa L. (Zingiberaceae) caused by hybridization with other curcuma species. AJPS 2011;2:111-119.
  8. Therapeutic uses of Curcuma longa (Turmeric). Indian J Clin Biochem 2001;16(2):153-160.
  9. Role of curcumin in systemic and oral health: An overview. J Nat Sci Biol Med 2013;4(1):3-7.
  10. Antibacterial activity of Curcuma longa varieties against different strains of bacteria. Pak J Bot 2010;42:455-462.
  11. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008;76(11):1590-1611.
  12. Insights into the virulence of oral biofilms: discoveries from proteomics. Expert Rev Proteomics 2012;9(3):311-323.
  13. Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm. J Oral Microbiol 2013;5:203-220.
  14. Schwalve, Moore and Goodwin, Crc Press; 2007.
  15. Fishing for new antimicrobials. Curr Opin Chem Biol 2006;10(4):327-333.
  16. Host responses in periodontal diseases: a preview. Periodontol 2000, 2007;43:9-13.
  17. Medicinal plants as antimicrobials In: Outline and pictures of medicinal plants from Nigeria. University of Lagos Press; p. 53-64.
  18. An in vitro evaluation of antibacterial activity of curcumin against common endodontic bacteria. J App Pharm Sci 2013;3(10):106-108.
  19. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J 2008;410(1):147-155.
  20. Inhibition of Staphylococcus epidermidis biofilm formation by traditional Thai herbal recipes used for wound treatment. Evid Based Complement Alternat Med 2012;2012:159797
  21. Curcumin as a promising anticandidal of clinical interest. Can J Microbiol 2011;57(3):204-210.
  22. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line. Nat Prod Commun 2010;5(12):1935-1938.
  23. Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock. Shock 2003;19:91-96.
  24. A preliminary report on anti inflammatory activity of curcumin. Ind J Pharmacol 1971;3:10.
  25. Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res 2011;46(2):269-279.
  26. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 2010;30:173-199.
  27. Antiangogenic effect of selected phytochemicals. Pharmazie 2010;65(1):57-63.
  28. Curcumin: a natural anti-inflammatory agent. Ind J Pharmacol 2005;37:141-147.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.